|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock based compensation for equity classified awards | |||||
| Pension expense | |||||
| Amortization of deferred financing cost | |||||
| Provision for bad debts | |||||
| Interest income on interest rate swap | |||||
| Accretion of contingent consideration | |||||
| Change in fair value of contingent consideration | |||||
| Deferred income taxes | |||||
| Impairment of assets | |||||
| Goodwill impairment | |||||
| (Loss) gain on sales of property | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Income taxes payable | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash paid for property and equipment | |||||
| Other investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from issuance of convertible preferred stock | |||||
| Payment of issuance costs for convertible preferred stock | |||||
| Payment of dividends | |||||
| Proceeds from long term debt | |||||
| Payment of deferred financing costs | |||||
| Payment of Dow liabilities settlement | |||||
| Payment for redemption of convertible preferred stock | |||||
| Repayment of long term debt | |||||
| Payments of contingent consideration | |||||
| Borrowings under revolving credit facility | |||||
| Repayments of revolving credit facility | |||||
| Settlement payment under Tax Receivables Agreement | |||||
| Proceeds from issuance of stock under employee stock purchase plan | |||||
| Net cash used in financing activities | |||||
| Cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| Accrued purchases of property and equipment | |||||
| Settlement of Dow liabilities not resulting from a cash payment | |||||
| Cash and cash equivalents | |||||
| Restricted cash within other current assets | |||||
Loading...